--(BUSINESS WIRE)--DiscoveryBioMed, Inc. is a life sciences and biotechnology company focused on integrating physiologically and disease relevant human cell platforms into the Drug Discovery Critical Path. In addition to our own discovery R&D, we offer services work in custom primary and immortal human cell culture and engineering and human cell-based bioassay and platform design for drug discovery and development. DBM offers its custom human cell-based methods as a “fee-for-service” support to researchers in both the commercial and academic spaces at the level of drug discovery, drug validation and/or lead prioritization in a number of different therapeutic areas. For more information, visit the DBM website at www.discoverybiomed.com.
